• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.69% Nasdaq Up 2.12%

    Alnylam Pharmaceuticals, Inc. (ALNY)

    -NasdaqGS
    96.45 4.37(4.75%) Dec 17, 4:00PM EST
    Add to Portfolio
    Prev Close:92.08
    Open:92.50
    Bid:91.00 x 100
    Ask:N/A
    1y Target Est:117.71
    Beta:2.17
    Earnings Date:Feb 11 - Feb 16 (Est.)
    Day's Range:91.12 - 96.54
    52wk Range:47.03 - 112.57
    Volume:573,234
    Avg Vol (3m):734,169
    Market Cap:7.42B
    P/E (ttm):N/A
    EPS (ttm):-5.25
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALNY

    Comparison

    Symbol% ChgMkt Cap
    ALNYUp 4.75%7.42B
    MRK164.30B
    PFE196.08B
    VRX46.99B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):189.46
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-5.37
    Quarterly EPS Est (Dec-14) :-0.60
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):-0.38

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback